Dry Powder Inhalers Market Size, Share and Forecast 2019-2026

SKU: DMD368 | Last Updated On: Oct 07 2019 | No. of Pages: 207 | Available Formats

Dry Powder Inhalers Market By Product Type (Capsule Based Device, Blister Based Devices, Reservoir/Cartridge Based Devices, Others), By Indication Type (Bronchitis, Chronic Obstructive Pulmonary Diseases, Asthma, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Drug Stores), and Region - Global Forecast.

Global Dry Powder Inhalers Market

  1. Global Dry Powder Inhalers Market Methodology and Scope
    1. Research methodology
    2. Research Objective and Scope of the Report
  2. Global Dry Powder Inhalers Market – Market Definition and Overview
  3. Global Dry Powder Inhalers Market – Executive Summary
    1. Market Snippet by Product Type
    2. Market Snippet by Indication Type
    3. Market Snippet by Distribution Channel
    4. Market Snippet by Region
  4. Global Dry Powder Inhalers Market – Market Dynamics
    1. Market Impacting Factors
    2. Drivers
      1. Increasing Prevalence Of Respiratory Devices
      2. Increasing Air Pollution Levels Especially In Developing Countries
    3. Restraints
      1. Inaccuracy In Dose Uniformity And High Cost Of Devices
    4. Impact Analysis
  5. Global Dry Powder Inhalers Market – Industry Analysis
    1. Porter's Five Forces Analysis
    2. Pricing Analysis
  6. Global Dry Powder Inhalers Market – By Product Type
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
    3. Market Attractiveness Index, by Product Type
    4. Capsule Based Device *
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
    5. Blister Based Devices
    6. Reservoir/Cartridge Based Devices
    7. Others
  7. Global Dry Powder Inhalers Market – by Indication Type
      1. Introduction
      2.  Market Size Analysis, and Y-o-Y Growth Analysis (%), by Indication Type
      3. Market Attractiveness Index, by Indication Type
    1.  Bronchitis*
      1. Introduction  
      2. Market Size Analysis, And Y-O-Y Growth Analysis (%)
    2. Chronic Obstructive Pulmonary Diseases (Copd)
    3. Asthma
    4. Others
  8. Global Dry Powder Inhalers Market – by Distribution Channel
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Distribution Channel
    3. Market Attractiveness Index, by Distribution Channel
    4. Hospital Pharmacies *
      1. Introduction  
      2. Market Size Analysis, And Y-O-Y Growth Analysis (%)
    5. Online Pharmacies
    6. Retail Pharmacies
    7. Drug Stores
  9. Global Dry Powder Inhalers Market – By Region
    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Indication Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Indication Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Indication Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Countries
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Indication Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Countries
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Distribution Channel
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Type
  10. Global Dry Powder Inhalers Market – Competitive Landscape
    1. Competitive Scenario
    2. Competitor Strategy Analysis
    3. Comparative Technology Portfolio Analysis
    4. Market Positioning/Share Analysis
    5. Mergers and Acquisitions Analysis
  11. Company Profiles
    1. AstraZeneca *
      1. Company overview
      2. Product portfolio and description
      3. Key highlights
      4. Financial overview
    2. GlaxoSmithKline plc
    3. Vectura Group plc
    4. Boehringer Ingelheim GmbH
    5. Otsuka Pharmaceutical Co. Ltd
    6. Norton Healthcare
    7. Respira Therapeutics, Inc
    8. Boehringer Ingelheim
    9. Chiesi
    10. Cipla
  12. Global Dry Powder Inhalers Market – Premium Insights
  13. Global Dry Powder Inhalers Market – DataM
    1. Appendix
    2. List of Tables and Figures
    3. About Us and Services
    4. Contact Us

List Of Tables

Table 1            Global Dry Powder Inhalers Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 2           Global Dry Powder Inhalers Market Value, By Indication, 2018,2022 & 2026 ($ Million)

Table 3           Global Dry Powder Inhalers Market Value, By Distribution Channel, 2018,2022 & 2026 ($ Million)

Table 4           Global Dry Powder Inhalers Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 5           Global Dry Powder Inhalers Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 6           Global Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 7           Global Dry Powder Inhalers Market Value, By Indication, 2018,2022 & 2026 ($ Million)

Table 8           Global Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 9           Global Dry Powder Inhalers Market Value, By Distribution Channel, 2018,2022 & 2026 ($ Million)

Table 10         Global Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 11          Global Dry Powder Inhalers Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 12         Global Dry Powder Inhalers Market Value, By Region, 2017-2026 ($ Million)

Table 13         North America Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 14         North America Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 15          North America Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 16         North America Dry Powder Inhalers Market Value, By Country, 2017-2026 ($ Million)

Table 17          South America Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 18         South America Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 19         South America Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 20         South America Dry Powder Inhalers Market Value, By Country, 2017-2026 ($ Million)

Table 21         Europe Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 22         Europe Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 23         Europe Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 24         Europe Dry Powder Inhalers Market Value, By Country, 2017-2026 ($ Million)

Table 25         Asia-Pacific Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 26         Asia-Pacific Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 27         Asia-Pacific Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 28         Asia-Pacific Dry Powder Inhalers Market Value, By Country, 2017-2026 ($ Million)

Table 29         Middle East & Africa Dry Powder Inhalers Market Value, By Product, 2017-2026 ($ Million)

Table 30         Middle East & Africa Dry Powder Inhalers Market Value, By Indication, 2017-2026 ($ Million)

Table 31         Middle East & Africa Dry Powder Inhalers Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 32         AstraZeneca: Overview

Table 33         AstraZeneca: Product Portfolio

Table 34         AstraZeneca: Key Developments

Table 35         GlaxoSmithKline plc: Overview

Table 36         GlaxoSmithKline plc: Product Portfolio

Table 37         GlaxoSmithKline plc: Key Developments

Table 38         Vectura Group plc: Overview

Table 39         Vectura Group plc: Product Portfolio

Table 40         Vectura Group plc: Key Developments

Table 41         Boehringer Ingelheim GmbH: Overview

Table 42         Boehringer Ingelheim GmbH: Product Portfolio

Table 43         Boehringer Ingelheim GmbH: Key Developments

Table 44         Otsuka Pharmaceutical Co. Ltd: Overview

Table 45         Otsuka Pharmaceutical Co. Ltd: Product Portfolio

Table 46         Otsuka Pharmaceutical Co. Ltd: Key Developments

Table 47         Norton Healthcare: Overview

Table 48         Norton Healthcare: Product Portfolio

Table 49         Norton Healthcare: Key Developments

Table 50         Respira Therapeutics, Inc: Overview

Table 51          Respira Therapeutics, Inc: Product Portfolio

Table 52         Respira Therapeutics, Inc: Key Developments

Table 53         Boehringer Ingelheim: Overview

Table 54         Boehringer Ingelheim: Product Portfolio

Table 55         Boehringer Ingelheim: Key Developments

Table 56         Chiesi: Overview

Table 57         Chiesi: Product Portfolio

Table 58         Chiesi: Key Developments

Table 59         Cipla: Overview

Table 60         Cipla: Product Portfolio

Table 61         Cipla: Key Developments

List Of Figures

Figure 1          Global Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 2         Global Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 3         Global Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 4         Global Dry Powder Inhalers Market Share, By Region, 2018 & 2026 (%)

Figure 5         Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 6         Global Dry Powder Inhalers Market Y-o-Y Growth, By Product, 2018-2026 (%)

Figure 7         Capsule Based Device : Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 8         Blister Based Devices: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 9         Reservoir/Cartridge Based Devices: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 10       Others: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 11        Global Dry Powder Inhalers Market Y-o-Y Growth, By Indication, 2018-2026 (%)

Figure 12       Bronchitis: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 13       Chronic Obstructive Pulmonary Diseases: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 14       Asthma: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 15        Others: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 16       Global Dry Powder Inhalers Market Y-o-Y Growth, By Distribution Channel, 2018-2026 (%)

Figure 17        Hospital Pharmacies : Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 18       Online Pharmacies: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 19       Retail Pharmacies: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 20       Drug Stores: Global Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 21       Global Dry Powder Inhalers Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 22       North America Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 23       North America Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 24       North America Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 25       North America Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 26       North America Dry Powder Inhalers Market Share, By Country, 2018 & 2026 (%)

Figure 27       South America Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 28       South America Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 29       South America Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 30       South America Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 31       South America Dry Powder Inhalers Market Share, By Country, 2018 & 2026 (%)

Figure 32       Europe Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 33       Europe Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 34       Europe Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 35       Europe Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 36       Europe Dry Powder Inhalers Market Share, By Country, 2018 & 2026 (%)

Figure 37       Asia-Pacific Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 38       Asia-Pacific Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 39       Asia-Pacific Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 40       Asia-Pacific Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 41       Asia-Pacific Dry Powder Inhalers Market Share, By Country, 2018 & 2026 (%)

Figure 42       Middle East & Africa Dry Powder Inhalers Market Value, 2017-2026 ($ Million)

Figure 43       Middle East & Africa Dry Powder Inhalers Market Share, By Product, 2018 & 2026 (%)

Figure 44       Middle East & Africa Dry Powder Inhalers Market Share, By Indication, 2018 & 2026 (%)

Figure 45       Middle East & Africa Dry Powder Inhalers Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 46       AstraZeneca: Financials

Figure 47       GlaxoSmithKline plc: Financials

Figure 48       Vectura Group plc: Financials

Figure 49       Boehringer Ingelheim GmbH: Financials

Figure 50       Otsuka Pharmaceutical Co. Ltd: Financials

Figure 51        Norton Healthcare: Financials

Figure 52       Respira Therapeutics, Inc: Financials

Figure 53       Boehringer Ingelheim: Financials

Figure 54       Chiesi: Financials

Figure 55       Cipla: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!